Beckman Coulter releases new assays to labs to test antipsychotic drug
Beckman Coulter has released new antipsychotic drug tests to laboratories and clinicians to address an unmet clinical need for 69 million people with serious mental conditions worldwide. The rapid, high-quality assays run on Beckman Coulter’s scalable AU clinical chemistry analysers and shorten turnaround time for patient test results to hours instead of days – leading […]